CClinicalTrials.gg
RecruitingNCT04808674EURECAUpdated Jan 13, 2023

Remediation for Mild Cognitive Deficits After Cancer

An interventional study of Cognitive remediation program in Cognitive Remediation and Breast Cancer, sponsored by Hospices Civils de Lyon. Recruiting at 2 sites in France. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-01-13.

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Dec 2021; still recruiting 4 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Cancer survival rates have improved significantly over the past decades and patients now experience a number of side effects including cancer-related cognitive impairment (CRCI): problems with memory, executive function, attention, and difficulties performing two tasks at the same time. The frequency of CRCI in cancer patients is estimated to be between 10 to 40%, and more than 50% of patients describe difficulties in their daily life. These cognitive difficulties negatively impact the patient's quality of life as well as that of their family, and can also have negative consequences for their social and professional reintegration once cancer treatment is finished. Despite an increasing number of studies on CRCI, a standard of care for patients with CRCI after breast cancer is yet to be established. In the absence of clear directives, and in an attempt to respond to the increasing demand to provide care for breast cancer patients with CRCI, physical medicine and rehabilitation units in France have started providing day-hospital multidisciplinary interventions. The objective of this project is to use the single case experimental design method to investigate the efficacy of two such rehabilitation programs: a group-based program and a one-on-one program.

02

Conditions studied

  • Cognitive Remediation
  • Breast Cancer

Keywords

  • Neuropsychology
  • psychological distress
  • quality of life
  • rehabilitation
03

In context

Cognition Disorders

411 studies on the registry are indexed under Cognition Disorders; 90 are open to participants now.

This study's planned enrollment of 24 is below the median of 60 across 287 interventional studies indexed under Cognition Disorders.

Browse Cognition Disorders studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Treated in the past for breast cancer with chemotherapy, surgery, and / or radiotherapy,
  • Admitted as a day patient at the Henry Gabrielle Hospital or the Pontchaillou CHU Hospital during the study,
  • Given free, informed consent in writing after being informed orally and in writing of the how the study will proceed.

Exclusion criteria

Exclusion Criteria:

  • Presence of another active cancer,
  • Ongoing chemotherapy and/or radiotherapy treatment,
  • Active progression of breast cancer,
  • History of neurological or psychiatric conditions,
  • Major disturbances in comprehension that prevent them giving free, informed consent,
  • Pregnant, parturient or breastfeeding women,
  • Person under a legal protection measure such as guardianship or curatorship,
  • People not affiliated to a social security scheme (French Social Security) or beneficiaries of a similar scheme.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Group-based cognitive remediation program

    Patients are admitted to the day hospital 2 days a week for 6 weeks and participate in a group-based (4 patients per group) rehabilitation program conducted by a multidisciplinary team including a PMR doctor, a neuropsychologist, an occupational therapist, and a physical activity monitor).

    Behavioral: Cognitive remediation program

  • Experimental
    One-on-one cognitive remediation program

    Patients are admitted to the day hospital 5 days a week for 6 weeks and participate in a one-on-one intensive rehabilitation program conducted by a multidisciplinary team including a speech therapist, neuropsychologist, occupational therapist, physiotherapist, physical activity monitor and a psychologist.

    Behavioral: Cognitive remediation program

Interventions

  • BehavioralCognitive remediation program

    Evaluation of REmediation programs for patients suffering from mild cognitive deficits after Cancer

06

What researchers measure

Primary outcomes

  1. Self-reported cognitive function

    The Fact-COG questionnaire assesses subjective cognitive impairment. The score directly reflects the patient's feelings about/perceptions of their cognitive function over the previous week. A total score out of 132 is obtained as well as 4 subscales: Perceived Cognitive Impairments (0-72), Impact on Quality of Life (0-16), Comments from Others (0-16), and Perceived Cognitive Abilities (0-28).

    Time frame: 16 weeks

Secondary outcomes

  1. Neuropsychological function

    Neuropsychological function will be measured using three sub-tests of the Test of Attentional Performance (alertness, covert shift of attention, divided attention), the Paced Auditory Serial Addition Test, the Montreal Cognitive neuropsychological Assessment, and the Symbol Digit Modalities Test.

    Time frame: 16 weeks

  2. Psychological distress

    Psychological distress will be measured using 4 questionnaires: The Hospital Anxiety and Depression Scale; the Brief Symptom Inventory-18; the Rosenberg self-esteem scale; the MCQ-30 Meta-cognition self-report questionnaire.

    Time frame: 16 weeks

  3. Quality of Life with FACT-B questionnaire

    The FACT-B questionnaire assesses cancer-related quality of life. A total score out of 148 is obtained as well as 5 subscales: Physical Well-Being (0-28), Social/Family Well-Being (0-28), Functional-Well-Being (0-28), Emotional Well-Being (0-24), and Breast Cancer Subscale (0-40).

    Time frame: 16 weeks

  4. Fatigue

    The FACTIT-Fatigue questionnaire assesses fatigue/ tiredness and its impact on daily activities and functioning in chronic disease. A total score out of 52 is obtained.

    Time frame: 16 weeks

07

Study locations

2 of 2 sites recruiting
  • Hospices Civils de Lyon - Groupement hospitalier sud - Hôpital Henry Gabrielle - Service de médecine physique et de réadaptation
    Lyon, 69230, France
    Recruiting
  • Hôpital Pontchaillou - Service de Médecine Physique et de Réadaptation
    Rennes, 35000, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04808674
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Mar 22, 2021
Start date
Dec 17, 2021
Primary completion
Jul 17, 2025 (estimated)
Completion
Jul 17, 2025 (estimated)
Last update
Jan 13, 2023

Study contacts

Sophie JACQUIN-COURTOIS, PhD
Contact
sophie.courtois@chu-lyon.fr
04.78.86.50.64
Mélanie COGNÉ, MD
Contact
melanie.cogne@chu-rennes.fr
02.99.28.42.18
Sophie JACQUIN-COURTOIS, PhD
principal investigator · Service de médecine physique et de réadaptation, HCL,

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion